BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 31272582)

  • 21. Pre-B-cell acute lymphoblastic leukemia with bulk extramedullary disease and chromosome 22 (EWSR1) rearrangement masquerading as Ewing sarcoma.
    Jakovljević G; Nakić M; Rogosić S; Kardum-Skelin I; Mrsić-Davidović S; Zadro R; Kruslin B
    Pediatr Blood Cancer; 2010 Apr; 54(4):606-9. PubMed ID: 20049929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B-lymphoblastic leukemia/lymphoma associated with t(8;13)(p11;q12)/ ZMYM2 (ZNF198)-FGFR1 : rare case and review of the literature.
    Trimaldi J; Carballido EM; Bowers JW; Anguiano AL; Zhang ZJ; Shah BD; Bruno S; List AF; Moscinski LC; Grady T; Agosti SJ; Kang L; Zhang L
    Acta Haematol; 2013; 130(3):127-34. PubMed ID: 23594707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MLL/GAS7 fusion in a pediatric case of t(11;17)(q23;p13)-positive precursor B-cell acute lymphoblastic leukemia.
    Panagopoulos I; Lilljebjörn H; Strömbeck B; Hjorth L; Olofsson T; Johansson B
    Haematologica; 2006 Sep; 91(9):1287-8. PubMed ID: 16956839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NUP214-ABL1 fusion defines a rare subtype of B-cell precursor acute lymphoblastic leukemia that could benefit from tyrosine kinase inhibitors.
    Duployez N; Grzych G; Ducourneau B; Alarcon Fuentes M; Grardel N; Boyer T; Abou Chahla W; Bruno B; Nelken B; Clappier E; Preudhomme C
    Haematologica; 2016 Apr; 101(4):e133-4. PubMed ID: 26681761
    [No Abstract]   [Full Text] [Related]  

  • 25. Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study.
    Lepretre S; Touzart A; Vermeulin T; Picquenot JM; Tanguy-Schmidt A; Salles G; Lamy T; Béné MC; Raffoux E; Huguet F; Chevallier P; Bologna S; Bouabdallah R; Benichou J; Brière J; Moreau A; Tallon-Simon V; Seris S; Graux C; Asnafi V; Ifrah N; Macintyre E; Dombret H
    J Clin Oncol; 2016 Feb; 34(6):572-80. PubMed ID: 26644537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. De novo B lymphoblastic leukemia/lymphoma in an adult with t(14;18)(q32;q21) and c-MYC gene rearrangement involving 10p13.
    Subramaniyam S; Fraser CR; Rao PH; Feldman E; Ely S; Mathew S
    Leuk Lymphoma; 2011 Nov; 52(11):2195-9. PubMed ID: 21718139
    [No Abstract]   [Full Text] [Related]  

  • 27. Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols.
    Ribera J; Morgades M; Zamora L; Montesinos P; Gómez-Seguí I; Pratcorona M; Sarrà J; Guàrdia R; Nomdedeu J; Tormo M; Martínez-Lopez J; Hernández-Rivas JM; González-Campos J; Barba P; Escoda L; Genescà E; Solé F; Millá F; Feliu E; Ribera JM;
    Cancer; 2015 Nov; 121(21):3809-17. PubMed ID: 26194343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute lymphoblastic leukaemia with an e1a3 BCR-ABL1 fusion.
    Langabeer SE; Haslam K; Kelly J; Leahy M; Vandenberghe E
    Acta Haematol; 2011; 126(4):214-5. PubMed ID: 21934295
    [No Abstract]   [Full Text] [Related]  

  • 29. ABL deletion without associated BCR-ABL in precursor B-cell acute lymphoblastic leukemia.
    Lo A; Gu G; Liu M; Dev VG
    Leuk Res; 2009 Aug; 33(8):e98-103. PubMed ID: 19282030
    [No Abstract]   [Full Text] [Related]  

  • 30. New genetic abnormalities and treatment response in acute lymphoblastic leukemia.
    Meijerink JP; den Boer ML; Pieters R
    Semin Hematol; 2009 Jan; 46(1):16-23. PubMed ID: 19100364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia.
    Wu SC; Li LS; Kopp N; Montero J; Chapuy B; Yoda A; Christie AL; Liu H; Christodoulou A; van Bodegom D; van der Zwet J; Layer JV; Tivey T; Lane AA; Ryan JA; Ng SY; DeAngelo DJ; Stone RM; Steensma D; Wadleigh M; Harris M; Mandon E; Ebel N; Andraos R; Romanet V; Dölemeyer A; Sterker D; Zender M; Rodig SJ; Murakami M; Hofmann F; Kuo F; Eck MJ; Silverman LB; Sallan SE; Letai A; Baffert F; Vangrevelinghe E; Radimerski T; Gaul C; Weinstock DM
    Cancer Cell; 2015 Jul; 28(1):29-41. PubMed ID: 26175414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complex MLL rearrangement in non-infiltrated bone marrow in an infant with stage II precursor B-lymphoblastic lymphoma.
    Ahlmann M; Meyer C; Marschalek R; Burkhardt B; Koehler G; Klapper W; Juergens H; Rossig C
    Eur J Haematol; 2014 Oct; 93(4):349-53. PubMed ID: 24635731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular diagnosis and clinical relevance of t(9;22), t(4;11) and t(1 ;19) chromosome abnormalities in a consecutive group of 141 adult patients with acute lymphoblastic leukemia.
    Rambaldi A; Attuati V; Bassan R; Neonato MG; Viero P; Battista R; Di Bona E; Rossi G; Pogliani E; Ruggeri M; Amaru R; Rivolta A; Giudici G; Biondi A; Barbui T
    Leuk Lymphoma; 1996 May; 21(5-6):457-66. PubMed ID: 9172811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergence of novel transient clonal chromosomal bone marrow changes in remission of acute lymphoblastic leukemia.
    Andreasson P; Johansson B; Arheden K; Tedgård U; Ljung R; Heim S; Mitelmann F
    Leukemia; 1996 Feb; 10(2):378-83. PubMed ID: 8637252
    [No Abstract]   [Full Text] [Related]  

  • 35. PAX5-ESRRB is a recurrent fusion gene in B-cell precursor pediatric acute lymphoblastic leukemia.
    Marincevic-Zuniga Y; Zachariadis V; Cavelier L; Castor A; Barbany G; Forestier E; Fogelstrand L; Heyman M; Abrahamsson J; Lönnerholm G; Nordgren A; Syvänen AC; Nordlund J
    Haematologica; 2016 Jan; 101(1):e20-3. PubMed ID: 26494837
    [No Abstract]   [Full Text] [Related]  

  • 36. Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase.
    Montenegro-Garreaud X; Miranda RN; Reynolds A; Tang G; Wang SA; Yabe M; Wang W; Fang L; Bueso-Ramos CE; Lin P; Medeiros LJ; Lu X
    Hum Pathol; 2017 Jul; 65():147-156. PubMed ID: 28551329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
    J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pure erythroid leukemia following precursor B-cell lymphoblastic leukemia.
    Xu M; Finn LS; Tsuchiya KD; Thomson B; Pollard J; Rutledge J
    Pediatr Dev Pathol; 2012; 15(1):76-8. PubMed ID: 21877942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. De Novo MYC and BCL2 Double-hit B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) in Pediatric and Young Adult Patients Associated With Poor Prognosis.
    Liu W; Hu S; Konopleva M; Khoury JD; Kalhor N; Tang G; Bueso-Ramos CE; Jorgensen JL; Lin P; Medeiros LJ; Lu X
    Pediatr Hematol Oncol; 2015; 32(8):535-47. PubMed ID: 26558423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ETV6-ABL1 fusion combined with monosomy 7 in childhood B-precursor acute lymphoblastic leukemia.
    Uemura S; Nishimura N; Hasegawa D; Shono A; Sakaguchi K; Matsumoto H; Nakamachi Y; Saegusa J; Yokoi T; Tahara T; Tamura A; Yamamoto N; Saito A; Kozaki A; Kishimoto K; Ishida T; Nino N; Takafuji S; Mori T; Iijima K; Kosaka Y
    Int J Hematol; 2018 May; 107(5):604-609. PubMed ID: 29177615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.